These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24416146)

  • 41. Limited advantages of intensity-modulated radiotherapy over 3D conformal radiation therapy in the adjuvant management of gastric cancer.
    Alani S; Soyfer V; Strauss N; Schifter D; Corn BW
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):562-6. PubMed ID: 19427558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute toxicity of postoperative intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for cervical cancer: The role of concomitant chemotherapy.
    Marjanovic D; Plesinac Karapandzic V; Stojanovic Rundic S; Tomasevic A; Saric M; Miskovic I; Nidzovic B; Petrasinovic P
    J BUON; 2019; 24(6):2347-2354. PubMed ID: 31983105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer - a retrospective single center analysis.
    Saleh-Ebrahimi L; Zwicker F; Muenter MW; Bischof M; Lindel K; Debus J; Huber PE; Roeder F
    Radiat Oncol; 2013 Jan; 8():20. PubMed ID: 23347410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized study for dosimetric assessment and clinical impact of bone marrow sparing intensity-modulated radiation therapy versus 3-dimensional conformal radiation therapy on hematological and gastrointestinal toxicities in cervical cancer.
    Kapoor AR; Bhalavat RL; Chandra M; Pareek V; Moosa Z; Markana S; Nandakumar P; Bauskar P; Shincy NV
    J Cancer Res Ther; 2022; 18(6):1490-1497. PubMed ID: 36412399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postoperative pelvic intensity-modulated radiation therapy reduced the incidence of late gastrointestinal complications for uterine cervical cancer patients.
    Tsuchida K; Murakami N; Kato T; Okuma K; Okamoto H; Kashihara T; Takahashi K; Inaba K; Igaki H; Nakayama Y; Nakano T; Itami J
    J Radiat Res; 2019 Oct; 60(5):650-657. PubMed ID: 31251358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study.
    Elson JK; Kachnic LA; Kharofa JR
    Cancer; 2018 Nov; 124(22):4383-4392. PubMed ID: 30329160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiation-induced acute toxicities after image-guided intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for patients with spinal metastases (IRON-1 trial) : First results of a randomized controlled trial.
    Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; El Shafie R; Nicolay NH; Debus J; Rief H
    Strahlenther Onkol; 2018 Oct; 194(10):911-920. PubMed ID: 29978307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
    Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
    Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers.
    Chen LA; Kim J; Boucher K; Terakedis B; Williams B; Nickman NA; Gaffney DK
    Gynecol Oncol; 2015 Mar; 136(3):521-8. PubMed ID: 25562668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma?
    Paumier A; Le Péchoux C; Beaudré A; Negretti L; Ferreira I; Roberti E; Brahim J; Lefkopoulos D; Daly-Schweitzer N; Bourhis J; Bonvalot S
    Radiother Oncol; 2011 Apr; 99(1):73-8. PubMed ID: 21439664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma.
    Yang H; Feng C; Cai BN; Yang J; Liu HX; Ma L
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27629865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study.
    Erpolat OP; Alco G; Caglar HB; Igdem S; Saran A; Dagoglu N; Aslay I; Ozsaran Z; Demirci S; Keven E; Guney Y; Akmansu M; Kilic D; Bayman E; Etiz D; Mandel NM
    Eur J Gynaecol Oncol; 2014; 35(1):62-6. PubMed ID: 24654465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
    Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
    [No Abstract]   [Full Text] [Related]  

  • 54. Efficacy and safety of intensity-modulated radiation therapy versus three-dimensional conformal radiation treatment for patients with gastric cancer: a systematic review and meta-analysis.
    Ren F; Li S; Zhang Y; Zhao Z; Wang H; Cui Y; Wang M
    Radiat Oncol; 2019 May; 14(1):84. PubMed ID: 31118042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparisons between the Dosimetric and Clinical Outcomes of Tomotherapy and 3D Conformal Radiotherapy in Gastric Cancer Treatment.
    Kucuktulu E; Yurekli AF; Topbas M; Kece C; Guner A; Kucuktulu U
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):595-599. PubMed ID: 30806065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac Function After Multimodal Breast Cancer Therapy Assessed With Functional Magnetic Resonance Imaging and Echocardiography Imaging.
    Heggemann F; Grotz H; Welzel G; Dösch C; Hansmann J; Kraus-Tiefenbacher U; Attenberger U; Schönberg SO; Borggrefe M; Wenz F; Papavassiliu T; Lohr F
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):836-44. PubMed ID: 26530752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intensity Modulated Radiation Therapy Reduces Gastrointestinal Toxicity in Patients Treated with Androgen Deprivation Therapy for Prostate Cancer.
    Sharma NK; Li T; Chen DY; Pollack A; Horwitz EM; Buyyounouski MK
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):S10. PubMed ID: 20664712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma.
    Mok H; Crane CH; Palmer MB; Briere TM; Beddar S; Delclos ME; Krishnan S; Das P
    Radiat Oncol; 2011 Jun; 6():63. PubMed ID: 21651775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancer.
    Trip AK; Nijkamp J; van Tinteren H; Cats A; Boot H; Jansen EP; Verheij M
    Radiother Oncol; 2014 Aug; 112(2):289-94. PubMed ID: 25241995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer.
    Samuelian JM; Callister MD; Ashman JB; Young-Fadok TM; Borad MJ; Gunderson LL
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1981-7. PubMed ID: 21477938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.